SCHEMBL15536129

SCHEMBL15536129

Cc1cccc(-c2c(C#N)cccc2C#N)c1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
NISCH Q9Y2I1 1/20 0.41
DRD2 P14416 2/20 0.41
HTR1A P08908 1/20 0.41
HTR7 P34969 1/20 0.41
PDK2 Q15119 1/20 0.39
USP8 P40818 1/20 0.39
AR P10275 1/20 0.38
ESR2 Q92731 1/20 0.36
LRRK2 Q5S007 2/20 0.36
LMNA P02545 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TRPA1 O75762 1/20 0.35
ATM Q13315 1/20 0.35
KDM1A O60341 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15536685 0.86 TSHR (0.61) TSHRNISCHDRD2HTR1AHTR7
SCHEMBL10578668 0.81 MYC (0.43) TSHRDRD2HTR1AHTR7PDK2
SCHEMBL21022697 0.81 TSHR (0.65) TSHRDRD2HTR1AHTR7PDK2
SCHEMBL29941499 0.81 TSHR (0.65) TSHRNISCHDRD2HTR1AHTR7
SCHEMBL102574 0.81 TSHR (0.65) TSHRNISCHDRD2HTR1AHTR7
SCHEMBL2186547 0.80 TSHR (0.59) TSHRNISCHDRD2HTR1AHTR7
SCHEMBL21022696 0.79 TSHR (0.62) TSHRDRD2HTR1AHTR7PDK2
Hydrochloric Acid SCHEMBL20840273 0.79 TSHR (0.62) TSHRNISCHDRD2HTR1AHTR7
SCHEMBL1132593 0.78 TSHR (0.61) TSHRNISCHDRD2HTR1AHTR7
SCHEMBL27909137 0.76 ESR2 (0.52) TSHRDRD2PDK2USP8ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855426-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS Orion Corporation (FI) 2015-04-08 EP claimed
WO-2013175053-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORPORATION (FI) 2013-11-28 WO claimed
US-20150218124-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS ORION CORPORATION (FI) 2015-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218124-A1 CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS COMT, PNMT, HNMT TSHR 2534/4885NISCH 3630/4885DRD2 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.